What do systematic reviews say?

Erythromycin vs nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 44 participants
  Very low

Erythromycin vs nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 213 participants
  Very low

Erythromycin vs nasogastric tube lavage

It is very uncertain whether erythromycin changes all‐cause mortality compared with nasogastric tube lavage (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RD 0.02
  3 studies · 213 participants
  Very low

Erythromycin vs nasogastric tube lavage

It is very uncertain whether erythromycin changes visualisation of gastric mucosa compared with nasogastric tube lavage (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RR 1.19 [0.79, 1.79]
  2 studies · 198 participants
  Very low

Erythromycin vs nasogastric tube lavage

It is very uncertain whether erythromycin changes NSAEs compared with nasogastric tube lavage (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 213 participants
  Very low

Erythromycin vs placebo

It is very uncertain whether erythromycin changes SAEs compared with placebo (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 255 participants
  Very low

Erythromycin vs nasogastric tube lavage

It is very uncertain whether erythromycin changes rebleeding compared with nasogastric tube lavage (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RR 0.77 [0.4, 1.49]
  1 study · 169 participants
  Very low

Erythromycin vs nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 169 participants
  Very low

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

The review found no eligible studies for this question.

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 30 participants
  Very low

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

The review found no eligible studies for this question.

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

It is very uncertain whether erythromycin plus nasogastric tube lavage changes visualisation of gastric mucosa compared with metoclopramide plus nasogastric tube lavage (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RR 1.3 [0.86, 1.96]
  1 study · 30 participants
  Very low

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 30 participants
  Very low

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

The review found no eligible studies for this question.

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 30 participants
  Very low

Erythromycin vs placebo

It is very uncertain whether erythromycin changes all‐cause mortality compared with placebo (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RD 0
  3 studies · 255 participants
  Very low

Erythromycin vs placebo

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 195 participants
  Low

Erythromycin vs placebo

It is very uncertain whether erythromycin changes NSAEs compared with placebo (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RD 0.01
  3 studies · 255 participants
  Very low

Erythromycin vs placebo

It is very uncertain whether erythromycin changes rebleeding compared with placebo (very low certainty).

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  RR 0.63 [0.13, 2.9]
  2 studies · 195 participants
  Very low

Erythromycin vs placebo

• Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 255 participants
  Low